// App-Quantinova.ai

Abstract 9030 : Effects of Edoxaban on Clinical Outcomes in Extremely Elderly Patients (aged ≥ 90 Years) With Atrial Fibrillation: A Subanalysis of Data from the ELDERCARE-AF Trial

Researchers

Presenter

  • Masaru Kuroda

Principal Investigators

  • Eiji Tamiya

  • Takahisa Nose

  • Akiyoshi Ogimoto

  • Junki Taura

  • Yuki Imamura

  • Masayuki Fukuzawa

  • Takuya Hayashi

  • Masaharu Akao

  • Takeshi Yamashita

  • Gregory Lip

  • Ken Okumura

Medical Centers

  • Uwajima City Hosp, Uwanjima Ehime, Japan

  • Cardiovascular Institute Hospital, Tokyo, Japan

  • Saiseikai Kyoto Hospital, Kyoto, Japan

  • Daiichi Sankyo Co., Ltd., Tokyo, Japan

  • Akashi Med Cntr, Hyogo, Japan

  • Univ of Liverpool and Liverpool Heart and Chest Hosp, Liverpool, United Kingdom

  • Nose Hosp, Hyogo, Japan

  • Department of Urology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan

  • Koto hospital, Tokyo, Japan

Locations

  • Japan

  • United Kingdom

Companies

  • Daiichi Sankyo Compa

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Non-valvular atrial fibrillation

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved